Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus

Metastatic renal cell carcinoma has harboured a poor prognosis for decades with immunotherapy being the only available therapy with high toxicity and modest effect. Dependance of renal cell carcinoma oncogenesis on the mTOR pathway has led to clinical development of temsirolimus in this setting. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadoux, Julien, Vignot, Stephane, De La Motte Rouge, Thibault
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018897/
https://www.ncbi.nlm.nih.gov/pubmed/21234295
http://dx.doi.org/10.4137/CMO.S4482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018897/
https://www.ncbi.nlm.nih.gov/pubmed/21234295
http://dx.doi.org/10.4137/CMO.S4482

Ejemplares similares